Overview
- Nexperia was placed under temporary external management on September 30 under the Goods Availability Act, with regular production allowed to continue and major decisions subject to Dutch approval for up to a year.
- An Amsterdam court suspended Wingtech chairman Zhang Xuezheng from Nexperia board roles and installed an independent non‑Chinese director with a deciding vote, while placing nearly all shares under a court‑appointed administrator.
- Published court findings say the CEO forced Nexperia to order up to $200 million of wafers from Shanghai firm WSS, where he had a stake, far above needs and risking obsolete inventory, which judges said bordered on recklessness.
- Court documents show U.S. officials told Dutch counterparts in June that replacing the CEO was likely necessary for export‑control relief, as new U.S. rules now extend entity‑list restrictions to majority‑owned subsidiaries such as Nexperia.
- Nexperia says China’s commerce ministry has barred Nexperia China and subcontractors from exporting certain components made in China, and the company is negotiating with both Washington and Beijing for exemptions; Wingtech’s shares fell by the daily 10% limit in Shanghai.